Thirteen of 25 patients in the standard therapy arm ( 52 % ) had an improvement of 1 or more in HESA score , thus meeting the primary outcome measure , compared with 21 of 23 evaluated patients receiving PEG ( 91 % ) ( P < .01 ) ; 1 patient was discharged before final analysis and 1 refused participation .